
The conference, according to the INS, will feature multiple daily tracks designed to provide attendees with the latest data on neuromodulation therapies to treat medical conditions that include chronic pain, hypertension, stroke, spinal cord injury (SCI), and traumatic brain injury (TBI). The society adds that an internationally renowned faculty and clinicians, engineers, researchers, and company representatives are expected to attend the conference.
A recent news release notes that the final extended deadline for conference abstracts is February 14, 2013.
To learn more, click here.
Source: INS